Serina Therapeutics(DE:2BO)
€1.26+0.03 (+2.44%)
DE:2BO
Serina Therapeutics earnings date
€1.26
At close:+0.03 (+2.44%)
Serina Therapeutics (2BO) Q4 2022 Earnings Report
1 Followers
DE:2BO Q4 2022 EPS Results
- Actual EPS
- -EUR 2.75
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 2.27
DE:2BO Q4 2022 Revenue Results
- Actual Revenue
- EUR 9,039.295
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +400.00%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 03/31/2023
- Time
- After Close
- Conference Call
- Friday, March 31, 2023
DE:2BO Upcoming Earnings
Serina Therapeutics's next earnings date is estimated for March 30, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2BO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 30, 2027 | 2026 (Q4) | -0.27- | -0.28 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.31-0.28 | -0.41 | 31.11% (+0.13) | |
| Aug 13, 2026 | 2026 (Q2) | -0.42-0.50 | -0.6 | 16.67% (+0.10) | |
| May 14, 2026 | 2026 (Q1) | -0.40-0.52 | -0.44 | -18.37% (-0.08) | |
| Mar 25, 2026 | 2025 (Q4) | -0.45-0.28 | -1.02 | 72.57% (+0.74) | |
| Nov 13, 2025 | 2025 (Q3) | -0.48-0.41 | 0.12 | -443.51% (-0.53) | |
| Aug 11, 2025 | 2025 (Q2) | -0.38-0.60 | 0.46 | -228.91% (-1.06) | |
| May 08, 2025 | 2025 (Q1) | -0.56-0.44 | -3.06 | 85.51% (+2.61) | |
| Mar 24, 2025 | 2024 (Q4) | 0.38-1.02 | -2.9 | 64.72% (+1.87) | |
| Nov 12, 2024 | 2024 (Q3) | ―0.12 | -4.52 | 102.62% (+4.64) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
